|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
WO1990006952A1
(fr)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Facteur de stimulation de colonies de granulocytes modifies chimiquement
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
GB9108652D0
(en)
|
1991-04-23 |
1991-06-12 |
Antisoma Ltd |
Immunoreactive compounds
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
CA2118508A1
(en)
|
1992-04-24 |
1993-11-11 |
Elizabeth S. Ward |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
|
DK0671927T3
(da)
|
1992-09-16 |
2003-04-22 |
Us Gov Health & Human Serv |
Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus
|
|
JP3919830B2
(ja)
|
1992-11-28 |
2007-05-30 |
財団法人化学及血清療法研究所 |
抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片
|
|
AU1866895A
(en)
|
1994-01-04 |
1995-08-01 |
Scripps Research Institute, The |
Human monoclonal antibodies to herpes simplex virus and methods therefor
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
WO1998052976A1
(en)
|
1997-05-21 |
1998-11-26 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
AU3657899A
(en)
|
1998-04-20 |
1999-11-08 |
James E. Bailey |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
|
GB9814383D0
(en)
|
1998-07-02 |
1998-09-02 |
Cambridge Antibody Tech |
Improvements relating to antibodies
|
|
EP1097172A1
(en)
|
1998-07-21 |
2001-05-09 |
Genmab A/S |
Anti hepatitis c virus antibody and uses thereof
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
PT1176195E
(pt)
|
1999-04-09 |
2013-07-18 |
Kyowa Hakko Kirin Co Ltd |
Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
KR100988949B1
(ko)
|
2001-10-25 |
2010-10-20 |
제넨테크, 인크. |
당단백질 조성물
|
|
US20040110704A1
(en)
|
2002-04-09 |
2004-06-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells of which genome is modified
|
|
CN101160324B
(zh)
|
2005-02-18 |
2013-04-24 |
米德列斯公司 |
缺乏岩藻糖残基的抗前列腺特异性膜抗原(psma)单克隆抗体
|
|
US9090694B2
(en)
*
|
2012-04-30 |
2015-07-28 |
Janssen Biotech, Inc. |
ST2L antibody antagonists
|
|
AR091069A1
(es)
|
2012-05-18 |
2014-12-30 |
Amgen Inc |
Proteinas de union a antigeno dirigidas contra el receptor st2
|
|
JO3532B1
(ar)
*
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
|
RU2693084C2
(ru)
*
|
2014-01-10 |
2019-07-01 |
Анаптисбайо, Инк. |
Антитела, направленные против интерлейкина-33 (il-33)
|
|
GB201403875D0
(en)
*
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
US10539572B2
(en)
*
|
2015-01-30 |
2020-01-21 |
Salk Institute For Biological Studies |
Compositions and methods for treating age-related diabetes and related disorders
|
|
CN108064236B
(zh)
*
|
2015-03-31 |
2021-12-10 |
免疫医疗有限公司 |
新颖的il33形式、il33的突变形式、抗体、测定及其使用方法
|
|
RU2740309C2
(ru)
*
|
2016-04-27 |
2021-01-13 |
Пфайзер Инк. |
Антитела против il-33, композиции, способы и их применение
|
|
CN107446040B
(zh)
*
|
2016-05-30 |
2021-01-12 |
深圳市安群生物工程有限公司 |
人st2抗原表位肽、抗原、抗体、试剂盒及应用
|
|
SG11202104120VA
(en)
*
|
2018-10-31 |
2021-05-28 |
Delinia Inc |
Multivalent regulatory t cell modulators
|
|
CN110357963B
(zh)
|
2019-07-31 |
2020-09-18 |
北京智仁美博生物科技有限公司 |
抗人st2抗体及其用途
|
|
US10577424B1
(en)
*
|
2019-08-15 |
2020-03-03 |
Beijing Mabworks Biotech Co., Ltd. |
Antibodies binding VISTA and uses thereof
|
|
CN113214395A
(zh)
*
|
2020-01-21 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
抗st2抗体及其应用
|